Cardiorenal Syndrome in End-Stage Kidney Disease

NCT ID: NCT02238093

Last Updated: 2014-09-12

Basic Information

• Recruitment Status: UNKNOWN
• Total Enrollment: 270 participants
• Study Classification: OBSERVATIONAL
• Study Start Date: 2014-10-31
• Study Completion Date: 2015-02-28

Brief Summary

Cardiorenal Syndrome (CRS) is prevalent among end-stage renal disease (ESRD) patients. Recently, its prevalence is rising. There are several different clinical presentations of this syndrome. It has a high rate of morbidity and mortality.

The purpose of this study is to find the connection between the heart pathology and its effect on ESRD patients. This will aid in choosing the appropriate medical therapy for these patients, and hopefully, aid in increasing their quality of life, and decrease their morbidity and mortality.

Conditions

End-stage Renal Disease; Cardiorenal Syndrome; Heart Disease

Study Design

• Observational Model Type: CASE_ONLY
• Study Time Perspective: RETROSPECTIVE

Study Groups

Dialysis Patients

End-stage renal disease patients undergoing dialysis at the Hillel Yaffe Medical Center.

No interventions assigned to this group

Eligibility Criteria

Inclusion Criteria

• End-stage renal patients

Exclusion Criteria

• Cancer patients

• Minimum Eligible Age: 18 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: No

Sponsors

Hillel Yaffe Medical Center

OTHER_GOV

Sponsor Role: lead

Responsible Party

Responsibility Role: SPONSOR

Principal Investigators

Noa Berar-Yanay, MD

Role: PRINCIPAL_INVESTIGATOR

Hillel Yaffe Medical Center

Locations

Hillel Yaffe Medical Center

Hadera, , Israel

Countries

Israel

Central Contacts

Noa Berar-Yanay, MD

Role: CONTACT

noab@hy.health.gov.il

972-4-630-4115

Other Identifiers

106-13-HYMC

Identifier Type: -

Identifier Source: org_study_id